DOI record:
{
"DOI": "10.1016/j.ijpharm.2025.125302",
"ISSN": [
"0378-5173"
],
"URL": "http://dx.doi.org/10.1016/j.ijpharm.2025.125302",
"alternative-id": [
"S0378517325001383"
],
"article-number": "125302",
"assertion": [
{
"label": "This article is maintained by",
"name": "publisher",
"value": "Elsevier"
},
{
"label": "Article Title",
"name": "articletitle",
"value": "Inhalable spray-dried dry powders combining ivermectin and niclosamide to inhibit SARS-CoV-2 infection in vitro"
},
{
"label": "Journal Title",
"name": "journaltitle",
"value": "International Journal of Pharmaceutics"
},
{
"label": "CrossRef DOI link to publisher maintained version",
"name": "articlelink",
"value": "https://doi.org/10.1016/j.ijpharm.2025.125302"
},
{
"label": "Content Type",
"name": "content_type",
"value": "article"
},
{
"label": "Copyright",
"name": "copyright",
"value": "© 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies."
}
],
"author": [
{
"affiliation": [],
"family": "Su",
"given": "Catherine",
"sequence": "first"
},
{
"affiliation": [],
"family": "Saha",
"given": "Tushar",
"sequence": "additional"
},
{
"ORCID": "https://orcid.org/0009-0008-5604-0358",
"affiliation": [],
"authenticated-orcid": false,
"family": "Sinha",
"given": "Shubhra",
"sequence": "additional"
},
{
"ORCID": "https://orcid.org/0009-0006-5166-0203",
"affiliation": [],
"authenticated-orcid": false,
"family": "Hird",
"given": "Cody P.",
"sequence": "additional"
},
{
"ORCID": "https://orcid.org/0009-0007-1181-165X",
"affiliation": [],
"authenticated-orcid": false,
"family": "Smith",
"given": "Sophie X.Y.",
"sequence": "additional"
},
{
"ORCID": "https://orcid.org/0000-0001-9170-5601",
"affiliation": [],
"authenticated-orcid": false,
"family": "Quiñones-Mateu",
"given": "Miguel E.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Das",
"given": "Shyamal C.",
"sequence": "additional"
}
],
"container-title": "International Journal of Pharmaceutics",
"container-title-short": "International Journal of Pharmaceutics",
"content-domain": {
"crossmark-restriction": true,
"domain": [
"elsevier.com",
"sciencedirect.com"
]
},
"created": {
"date-parts": [
[
2025,
1,
30
]
],
"date-time": "2025-01-30T22:26:02Z",
"timestamp": 1738275962000
},
"deposited": {
"date-parts": [
[
2025,
2,
1
]
],
"date-time": "2025-02-01T16:48:17Z",
"timestamp": 1738428497000
},
"funder": [
{
"DOI": "10.13039/501100001563",
"doi-asserted-by": "publisher",
"id": [
{
"asserted-by": "publisher",
"id": "10.13039/501100001563",
"id-type": "DOI"
}
],
"name": "Otago Medical Research Foundation"
}
],
"indexed": {
"date-parts": [
[
2025,
2,
2
]
],
"date-time": "2025-02-02T05:31:59Z",
"timestamp": 1738474319235,
"version": "3.35.0"
},
"is-referenced-by-count": 0,
"issued": {
"date-parts": [
[
2025,
2
]
]
},
"language": "en",
"license": [
{
"URL": "https://www.elsevier.com/tdm/userlicense/1.0/",
"content-version": "tdm",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2025,
2,
1
]
],
"date-time": "2025-02-01T00:00:00Z",
"timestamp": 1738368000000
}
},
{
"URL": "https://www.elsevier.com/legal/tdmrep-license",
"content-version": "tdm",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2025,
2,
1
]
],
"date-time": "2025-02-01T00:00:00Z",
"timestamp": 1738368000000
}
},
{
"URL": "https://doi.org/10.15223/policy-017",
"content-version": "stm-asf",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2025,
2,
1
]
],
"date-time": "2025-02-01T00:00:00Z",
"timestamp": 1738368000000
}
},
{
"URL": "https://doi.org/10.15223/policy-037",
"content-version": "stm-asf",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2025,
2,
1
]
],
"date-time": "2025-02-01T00:00:00Z",
"timestamp": 1738368000000
}
},
{
"URL": "https://doi.org/10.15223/policy-012",
"content-version": "stm-asf",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2025,
2,
1
]
],
"date-time": "2025-02-01T00:00:00Z",
"timestamp": 1738368000000
}
},
{
"URL": "https://doi.org/10.15223/policy-029",
"content-version": "stm-asf",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2025,
2,
1
]
],
"date-time": "2025-02-01T00:00:00Z",
"timestamp": 1738368000000
}
},
{
"URL": "https://doi.org/10.15223/policy-004",
"content-version": "stm-asf",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2025,
2,
1
]
],
"date-time": "2025-02-01T00:00:00Z",
"timestamp": 1738368000000
}
}
],
"link": [
{
"URL": "https://api.elsevier.com/content/article/PII:S0378517325001383?httpAccept=text/xml",
"content-type": "text/xml",
"content-version": "vor",
"intended-application": "text-mining"
},
{
"URL": "https://api.elsevier.com/content/article/PII:S0378517325001383?httpAccept=text/plain",
"content-type": "text/plain",
"content-version": "vor",
"intended-application": "text-mining"
}
],
"member": "78",
"original-title": [],
"page": "125302",
"prefix": "10.1016",
"published": {
"date-parts": [
[
2025,
2
]
]
},
"published-print": {
"date-parts": [
[
2025,
2
]
]
},
"publisher": "Elsevier BV",
"reference": [
{
"DOI": "10.3390/pharmaceutics12080715",
"article-title": "Co-Amorphization of Kanamycin with Amino Acids Improves Aerosolization",
"author": "Adhikari",
"doi-asserted-by": "crossref",
"first-page": "715",
"journal-title": "Pharmaceutics.",
"key": "10.1016/j.ijpharm.2025.125302_b0005",
"volume": "12",
"year": "2020"
},
{
"article-title": "Optimization of methionine in inhalable High-dose Spray-dried amorphous composite particles using response surface Method, infrared and low frequency Raman spectroscopy",
"author": "Adhikari",
"journal-title": "Int J Pharm.",
"key": "10.1016/j.ijpharm.2025.125302_b0010",
"volume": "614",
"year": "2022"
},
{
"DOI": "10.1016/j.ijpharm.2022.121688",
"article-title": "Pharmacokinetics and safety of inhaled ivermectin in mice as a potential COVID-19 treatment",
"author": "Albariqi",
"doi-asserted-by": "crossref",
"journal-title": "Int J Pharm.",
"key": "10.1016/j.ijpharm.2025.125302_b0015",
"volume": "619",
"year": "2022"
},
{
"DOI": "10.1016/j.isci.2020.101303",
"doi-asserted-by": "crossref",
"key": "10.1016/j.ijpharm.2025.125302_b0020",
"unstructured": "Altay. O., Mohammadi, E., Lam, S., Turkez, H., Boren, J., Nielsen, J., Uhlen, M., Mardinoglu, A., 2020. Current Status of COVID-19 Therapies and Drug Repositioning Applications. iScience. 23,101303."
},
{
"DOI": "10.1021/acs.molpharmaceut.9b00496",
"article-title": "Effect of Particle Formation Process on Characteristics and Aerosol Performance of Respirable Protein Powders",
"author": "Brunaugh",
"doi-asserted-by": "crossref",
"first-page": "4165",
"journal-title": "Mol Pharm.",
"key": "10.1016/j.ijpharm.2025.125302_b0025",
"volume": "16",
"year": "2019"
},
{
"DOI": "10.1001/jamanetworkopen.2021.44942",
"article-title": "Efficacy of Niclosamide vs Placebo in SARS-CoV-2 Respiratory Viral Clearance, Viral Shedding, and Duration of Symptoms Among Patients With Mild to Moderate COVID-19: A Phase 2 Randomized Clinical Trial",
"author": "Cairns",
"doi-asserted-by": "crossref",
"first-page": "e2144942",
"journal-title": "JAMA Netw Open.",
"key": "10.1016/j.ijpharm.2025.125302_b0030",
"volume": "5",
"year": "2022"
},
{
"DOI": "10.1016/j.antiviral.2020.104787",
"article-title": "The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro",
"author": "Caly",
"doi-asserted-by": "crossref",
"journal-title": "Antiviral Res.",
"key": "10.1016/j.ijpharm.2025.125302_b0035",
"volume": "178",
"year": "2020"
},
{
"DOI": "10.1517/17425247.5.8.909",
"article-title": "What is the role of particle morphology in pharmaceutical powder aerosols?",
"author": "Chan",
"doi-asserted-by": "crossref",
"first-page": "909",
"journal-title": "Expert Opin Drug Deliv.",
"key": "10.1016/j.ijpharm.2025.125302_b0040",
"volume": "5",
"year": "2008"
},
{
"DOI": "10.3390/pharmaceutics13010031",
"article-title": "Dry powder for pulmonary delivery: a comprehensive review",
"author": "Chaurasiya",
"doi-asserted-by": "crossref",
"first-page": "31",
"journal-title": "Pharmaceutics.",
"key": "10.1016/j.ijpharm.2025.125302_b0045",
"volume": "13",
"year": "2020"
},
{
"DOI": "10.1021/acsptsci.1c00022",
"article-title": "Synergistic Inhibition of SARS-CoV-2 Replication Using Disulfiram/Ebselen and Remdesivir",
"author": "Chen",
"doi-asserted-by": "crossref",
"first-page": "898",
"journal-title": "ACS Pharmacol Transl Sci.",
"key": "10.1016/j.ijpharm.2025.125302_b0050",
"volume": "4",
"year": "2021"
},
{
"DOI": "10.3390/ph15040445",
"article-title": "Antiviral Activity of Repurposing Ivermectin against a Panel of 30 Clinical SARS-CoV-2 Strains Belonging to 14 Variants",
"author": "Delandre",
"doi-asserted-by": "crossref",
"first-page": "445",
"journal-title": "Pharmaceuticals (basel).",
"key": "10.1016/j.ijpharm.2025.125302_b0055",
"volume": "15",
"year": "2022"
},
{
"DOI": "10.1016/j.powtec.2018.10.041",
"doi-asserted-by": "crossref",
"key": "10.1016/j.ijpharm.2025.125302_b0060",
"unstructured": "Gallo, L., Verónica, Ramírez-Rigo, M., Bucalá, V., 2019. Development of porous spray-dried inhalable particles using an organic solvent-free technique. Powder Technol. 342,642-52."
},
{
"DOI": "10.6028/jres.081A.011",
"article-title": "Humidity fixed points of binary saturated aqueous solutions",
"author": "Greenspan",
"doi-asserted-by": "crossref",
"first-page": "89",
"journal-title": "J Res Natl Bur Stand A Phys Chem.",
"key": "10.1016/j.ijpharm.2025.125302_b0065",
"volume": "81A",
"year": "1977"
},
{
"DOI": "10.1016/j.jinf.2024.106130",
"doi-asserted-by": "crossref",
"key": "10.1016/j.ijpharm.2025.125302_b0070",
"unstructured": "Hayward, G., Yu, L.M., Little, P., Gbinigie, O., Shanyinde, M., Harris, V., Dorward, J., Saville, B.R., Berry, N., Evans, P.H., Thomas, N.P.B., Patel, M.G., Richards, D., Hecke, O.V., Detry, M.A., Saunders, C., Fitzgerald, M., Robinson, J., Latimer-Bell, C., Allen, J., Ogburn, E., Grabey, J., de Lusignan, S., Hobbs, F.R., Butler, C.C., PRINCIPLE Trial Collaborative Group., 2024. Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes. J Infect. 88,106130."
},
{
"DOI": "10.1016/0021-8502(86)90035-2",
"article-title": "Deposition of particles in the human respiratory tract in the size range 0.005–15 μm",
"author": "Heyder",
"doi-asserted-by": "crossref",
"first-page": "811",
"journal-title": "J Aerosol Sci.",
"key": "10.1016/j.ijpharm.2025.125302_b0075",
"volume": "17",
"year": "1986"
},
{
"DOI": "10.1093/cid/ciac769",
"article-title": "Remdesivir Resistance in Transplant Recipients With Persistent Coronavirus Disease 2019",
"author": "Hogan",
"doi-asserted-by": "crossref",
"first-page": "342",
"journal-title": "Clin Infect Dis.",
"key": "10.1016/j.ijpharm.2025.125302_b0080",
"volume": "76",
"year": "2023"
},
{
"DOI": "10.1016/j.ijpharm.2021.120701",
"article-title": "Niclosamide inhalation powder made by thin-film freezing: Multi-dose tolerability and exposure in rats and pharmacokinetics in hamsters",
"author": "Jara",
"doi-asserted-by": "crossref",
"journal-title": "Int J Pharm.",
"key": "10.1016/j.ijpharm.2025.125302_b0085",
"volume": "603",
"year": "2021"
},
{
"DOI": "10.1128/AAC.00819-20",
"article-title": "Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs",
"author": "Jeon",
"doi-asserted-by": "crossref",
"first-page": "e00819",
"journal-title": "Antimicrob Agents Chemother.",
"key": "10.1016/j.ijpharm.2025.125302_b0090",
"volume": "64",
"year": "2020"
},
{
"DOI": "10.1186/s40360-022-00580-8",
"article-title": "Synergistic anti-SARS-CoV-2 activity of repurposed anti-parasitic drug combinations",
"author": "Jitobaom",
"doi-asserted-by": "crossref",
"first-page": "41",
"journal-title": "BMC Pharmacol Toxicol.",
"key": "10.1016/j.ijpharm.2025.125302_b0095",
"volume": "23",
"year": "2022"
},
{
"DOI": "10.4014/jmb.2110.10029",
"article-title": "COVID-19 Drug Development",
"author": "Kim",
"doi-asserted-by": "crossref",
"first-page": "1",
"journal-title": "J Microbiol Biotechnol.",
"key": "10.1016/j.ijpharm.2025.125302_b0100",
"volume": "32",
"year": "2022"
},
{
"DOI": "10.1007/s40005-017-0359-z",
"article-title": "Dry powder inhaler for pulmonary drug delivery: human respiratory system, approved products and therapeutic equivalence guideline",
"author": "Lee",
"doi-asserted-by": "crossref",
"first-page": "603",
"journal-title": "J Pharm Investig.",
"key": "10.1016/j.ijpharm.2025.125302_b0105",
"volume": "48",
"year": "2017"
},
{
"DOI": "10.1016/j.ejmech.2023.115320",
"article-title": "Synthesis, cytotoxicity, and pharmacokinetic evaluations of niclosamide analogs for anti-SARS-CoV-2",
"author": "Li",
"doi-asserted-by": "crossref",
"journal-title": "Eur J Med Chem.",
"key": "10.1016/j.ijpharm.2025.125302_b0110",
"volume": "253",
"year": "2023"
},
{
"key": "10.1016/j.ijpharm.2025.125302_b0115",
"unstructured": "Lim, S.C.L., Hor, C.P., Tay, K.H., Mat Jelani, A., Tan, W.H., Ker, H.B, Chow, T.S., Zaid, M., Cheah, W.K., Lim, H.H., Khalid, K.E., Cheng, J.T., Mohd, Unit H., An, N., Nasruddin, A.B., Low, L.L., Khoo, S.W.R., Loh, J.H., Zaidan, N.Z., Ab, Wahab. S., Song, L.H., Koh, H.M., King, T.L., Lai, N.M., Chidambaram, S.K., Peariasamy, K.M., I-TECH Study Group., 2022. Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities: The I-TECH Randomized Clinical Trial. JAMA Intern Med. 182,426-435."
},
{
"DOI": "10.1001/jama.2021.3071",
"article-title": "Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: A Randomized Clinical Trial",
"author": "López-Medina",
"doi-asserted-by": "crossref",
"first-page": "1426",
"journal-title": "JAMA.",
"key": "10.1016/j.ijpharm.2025.125302_b0120",
"volume": "325",
"year": "2021"
},
{
"DOI": "10.1016/j.ijpharm.2017.06.004",
"article-title": "Dry powder formulation of kanamycin with enhanced aerosolization efficiency for drug-resistant tuberculosis",
"author": "Momin",
"doi-asserted-by": "crossref",
"first-page": "107",
"journal-title": "Int J Pharm.",
"key": "10.1016/j.ijpharm.2025.125302_b0125",
"volume": "528",
"year": "2017"
},
{
"DOI": "10.1016/j.ijpharm.2018.08.061",
"article-title": "High dose dry powder inhalers to overcome the challenges of tuberculosis treatment",
"author": "Momin",
"doi-asserted-by": "crossref",
"first-page": "398",
"journal-title": "Int J Pharm.",
"key": "10.1016/j.ijpharm.2025.125302_b0130",
"volume": "550",
"year": "2018"
},
{
"DOI": "10.3390/pharmaceutics13081254",
"article-title": "Roflumilast Powders for Chronic Obstructive Pulmonary Disease: Formulation Design and the Influence of Device, Inhalation Flow Rate, and Storage Relative Humidity on Aerosolization",
"author": "Momin",
"doi-asserted-by": "crossref",
"first-page": "1254",
"journal-title": "Pharmaceutics.",
"key": "10.1016/j.ijpharm.2025.125302_b0135",
"volume": "13",
"year": "2021"
},
{
"DOI": "10.1039/D0RA07203F",
"article-title": "Advanced design and development of nanoparticle/microparticle dual-drug combination lactose carrier-free dry powder inhalation aerosols",
"author": "Muralidharan",
"doi-asserted-by": "crossref",
"first-page": "41846",
"journal-title": "RSC Adv.",
"key": "10.1016/j.ijpharm.2025.125302_b0140",
"volume": "10",
"year": "2020"
},
{
"DOI": "10.1101/2022.12.15.22283488",
"doi-asserted-by": "crossref",
"key": "10.1016/j.ijpharm.2025.125302_b0145",
"unstructured": "Naggie, S., Boulware, D.R., Lindsell, C.J., Stewart, T.G., Slandzicki, A.J., Lim, S.C., Cohen, J., Kavtaradze, D., Amon, A.P., Gabriel, A., Gentile, N., Felker, G.M., Jayaweera, D., McCarthy, M.W., Sulkowski, M., Rothman, R.L., Wilson, S., DeLong, A., Remaly, A., Wilder, R., Collins, S., Dunsmore, S.E., Adam, S.J., Thicklin, F., Hanna, G.J., Ginde, A.A., Castro, M., McTigue, K., Shenkman, E., Hernandez, A.F., Accelerating Covid-19 Therapeutic Interventions and Vaccines (ACTIV)-6 Study Group and Investigators., 2023. Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial. JAMA. 329,888-897."
},
{
"DOI": "10.1016/S0378-5173(02)00359-9",
"article-title": "The influence of relative humidity on particulate interactions in carrier-based dry powder inhaler formulations",
"author": "Price",
"doi-asserted-by": "crossref",
"first-page": "47",
"journal-title": "Int J Pharm.",
"key": "10.1016/j.ijpharm.2025.125302_b0150",
"volume": "246",
"year": "2002"
},
{
"article-title": "Fabrication of Niclosamide loaded solid lipid nanoparticles: in vitro characterization and comparative in vivo evaluation",
"author": "Rehman",
"first-page": "1926",
"journal-title": "Artif Cells Nanomed Biotechnol.",
"key": "10.1016/j.ijpharm.2025.125302_b0155",
"volume": "46",
"year": "2018"
},
{
"DOI": "10.1016/j.ijpharm.2022.122042",
"article-title": "Inhaled therapy for COVID-19: Considerations of drugs, formulations and devices",
"author": "Saha",
"doi-asserted-by": "crossref",
"journal-title": "Int J Pharm.",
"key": "10.1016/j.ijpharm.2025.125302_b0160",
"volume": "624",
"year": "2022"
},
{
"DOI": "10.3390/pharmaceutics14071432",
"article-title": "Manipulation of Spray-Drying Conditions to Develop an Inhalable Ivermectin Dry Powder",
"author": "Saha",
"doi-asserted-by": "crossref",
"first-page": "1432",
"journal-title": "Pharmaceutics.",
"key": "10.1016/j.ijpharm.2025.125302_b0165",
"volume": "14",
"year": "2022"
},
{
"DOI": "10.1016/j.ijpharm.2023.123411",
"article-title": "Inhalable dry powder containing remdesivir and disulfiram: Preparation and in vitro characterization",
"author": "Saha",
"doi-asserted-by": "crossref",
"journal-title": "Int J Pharm.",
"key": "10.1016/j.ijpharm.2025.125302_b0170",
"volume": "645",
"year": "2023"
},
{
"DOI": "10.3390/pharmaceutics15092229",
"article-title": "Spray-Dried Inhalable Microparticles Combining Remdesivir and Ebselen against SARS-CoV-2 Infection",
"author": "Saha",
"doi-asserted-by": "crossref",
"first-page": "2229",
"journal-title": "Pharmaceutics.",
"key": "10.1016/j.ijpharm.2025.125302_b0175",
"volume": "15",
"year": "2023"
},
{
"DOI": "10.1016/j.ejpb.2023.12.010",
"article-title": "Repurposing ebselen as an inhalable dry powder to treat respiratory tract infections",
"author": "Saha",
"doi-asserted-by": "crossref",
"journal-title": "Eur J Pharm Biopharm.",
"key": "10.1016/j.ijpharm.2025.125302_b0180",
"volume": "195",
"year": "2024"
},
{
"DOI": "10.1007/978-1-4419-9745-6_3",
"doi-asserted-by": "crossref",
"key": "10.1016/j.ijpharm.2025.125302_b0185",
"unstructured": "Sanders, M. 2011. Pulmonary drug delivery: An historical overview. In: Smyth HDC, Hickey AJ, editors. Controlled pulmonary drug delivery. New York, NY: Springer New York, p. 51-73."
},
{
"DOI": "10.1021/cg300784v",
"article-title": "Pharmaceutical Cocrystals of Niclosamide",
"author": "Sanphui",
"doi-asserted-by": "crossref",
"first-page": "4588",
"journal-title": "Crystal Growth & Design.",
"key": "10.1016/j.ijpharm.2025.125302_b0190",
"volume": "12",
"year": "2012"
},
{
"DOI": "10.1007/s11095-020-02890-0",
"article-title": "Solvent-Assisted Secondary Drying of Spray-Dried Polymers",
"author": "Shepard",
"doi-asserted-by": "crossref",
"first-page": "156",
"journal-title": "Pharm Res.",
"key": "10.1016/j.ijpharm.2025.125302_b0195",
"volume": "37",
"year": "2020"
},
{
"DOI": "10.1016/j.drudis.2021.05.008",
"article-title": "Drug combination therapy for emerging viral diseases",
"author": "Shyr",
"doi-asserted-by": "crossref",
"first-page": "2367",
"journal-title": "Drug Discov Today.",
"key": "10.1016/j.ijpharm.2025.125302_b0200",
"volume": "26",
"year": "2021"
},
{
"DOI": "10.1007/s43440-020-00155-6",
"article-title": "Drug repurposing approach to fight COVID-19",
"author": "Singh",
"doi-asserted-by": "crossref",
"first-page": "1479",
"journal-title": "Pharmacol Rep.",
"key": "10.1016/j.ijpharm.2025.125302_b0205",
"volume": "72",
"year": "2020"
},
{
"DOI": "10.1016/j.ijpharm.2013.01.003",
"article-title": "Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: effect of spray drying process conditions on aerosol performance",
"author": "Son",
"doi-asserted-by": "crossref",
"first-page": "137",
"journal-title": "Int J Pharm.",
"key": "10.1016/j.ijpharm.2025.125302_b0210",
"volume": "443",
"year": "2013"
},
{
"DOI": "10.1126/scitranslmed.abo0718",
"article-title": "Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms",
"author": "Stevens",
"doi-asserted-by": "crossref",
"first-page": "eabo0718",
"journal-title": "Sci Transl Med.",
"key": "10.1016/j.ijpharm.2025.125302_b0215",
"volume": "14",
"year": "2022"
},
{
"DOI": "10.1038/s41467-020-19055-7",
"article-title": "A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19",
"author": "Xie",
"doi-asserted-by": "crossref",
"first-page": "5214",
"journal-title": "Nat Commun.",
"key": "10.1016/j.ijpharm.2025.125302_b0220",
"volume": "11",
"year": "2020"
},
{
"DOI": "10.1136/bmjresp-2020-000830",
"doi-asserted-by": "crossref",
"key": "10.1016/j.ijpharm.2025.125302_b0225",
"unstructured": "Yamada, S., Fukushi, S., Kinoshita, H., Ohnishi, M., Suzuki, T., Fujimoto, T., Saijo, M., Maeda, K., Virus Diagnosis Group (NIID Toyama)., 2021. Assessment of SARS-CoV-2 infectivity of upper respiratory specimens from COVID-19 patients by virus isolation using VeroE6/TMPRSS2 cells. BMJ Open Respir Res. 8,e000830."
}
],
"reference-count": 45,
"references-count": 45,
"relation": {},
"resource": {
"primary": {
"URL": "https://linkinghub.elsevier.com/retrieve/pii/S0378517325001383"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"special_numbering": "C",
"subject": [],
"subtitle": [],
"title": "Inhalable spray-dried dry powders combining ivermectin and niclosamide to inhibit SARS-CoV-2 infection in vitro",
"type": "journal-article",
"update-policy": "https://doi.org/10.1016/elsevier_cm_policy",
"volume": "671"
}
